The Relationship Between Quality of Life and Coping Strategies in Polycystic Ovary Syndrome Patients

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2015 Oct 6

PMID 26436082

Citations 7

Authors

Leila Kolahi

Neda Asemi

Mohammadreza Mirzaei

Neda Adibi

Mina Beiraghdar

Asieh Maghami Mehr

Affiliations

Soon will be listed here.

Abstract

Background: There are many factors that affect the quality of life, for example, stress and the coping strategies. Polycystic ovary syndrome is a common hormonal disorder leading to menstrual disorders, hirsutism, acne, obesity, infertility and abortion. In such cases, the patients suffer from a variety of stresses and face problems in their coping strategies with life's problems which can affect the quality of life and cause psychological distress and low the quality of life. The quality of life is a descriptive term which points to health and emotional, social and physical promotion of individuals as well as their ability to perform daily living tasks. The purpose of this study was to investigate the relationship between quality of life and coping strategies in patients with polycystic ovary syndrome.

Materials And Methods: To perform this study, randomly 200 women who had inclusion criteria and were referred to Ali Shariati Hospital in Isfahan were selected and responded DLQI questionnaire and Carver coping strategies and form of demographic characteristics.

Results: The mean score of quality of life in the patients was 4.14 ± 5.57. It was shown that acne has no effective role on quality of life and coping strategies in contrast in hirsute and non-hirsute patients; there was a significant difference in quality of life P value < 0.001). Also there is a significant relationship between the quality of life and coping strategies (problem solving, cognitive, emotional and social support) (P < 0.05) and quality of life has the highest correlation with emotional strategies (r = 0.46).

Conclusion: According to results of this study, patients with PCOS are at risk pcychologicla disorders that may be led to decrease of quality of life. Thus this patients need to support by oppositions strategies. Also not only physical treatment but also psychological surveillance especially social support must be done for them.

Citing Articles

Assessment of the Validity and Quality of Polycystic Ovarian Syndrome (PCOS) Screening Tools Available for Women Globally: A Systematic Review.

Sacca L, Lobaina D, Knopf E, Burgoa S, Jimenez S, Okwaraji G Clin Pract. 2024; 14(5):1625-1649.

PMID: 39311281 PMC: 11417729. DOI: 10.3390/clinpract14050131.

Polycystic Ovary Syndrome: A Comprehensive Exploration of Diagnosis Experience in Saudi Women.

Alqntash N, AlZabin A, Almajed E, Alotaibi K, Alhindi G, Ali S J Clin Med. 2024; 13(17).

PMID: 39274518 PMC: 11395902. DOI: 10.3390/jcm13175305.

Assessment of Health-Related Quality of Life Using PCOSQ Tool, Its Determinants and Coping Mechanisms Used by Women with Polycystic Ovarian Syndrome Attending Multidisciplinary Clinic in Mumbai, India.

Joshi B, Patil A, Kokate P, Akula A, Shaikh S, Tandon D J Obstet Gynaecol India. 2023; 73(2):172-179.

PMID: 37073232 PMC: 10105802. DOI: 10.1007/s13224-022-01723-x.

Anxiety and Depression in Women with Polycystic Ovary Syndrome.

Dybciak P, Humeniuk E, Raczkiewicz D, Krakowiak J, Wdowiak A, Bojar I Medicina (Kaunas). 2022; 58(7).

PMID: 35888661 PMC: 9319705. DOI: 10.3390/medicina58070942.

Experiences of cancer rehabilitation among patients in rural areas in northern Iceland: physical and psychosocial well-being, coping, quality of life, and satisfaction with care. A qualitative study.

Bjornsdottir E, Hjorleifsdottir E, Sigurdardottir B, Baruchello G, Bormodsson F Int J Circumpolar Health. 2021; 80(1):1936974.

PMID: 34114531 PMC: 8204953. DOI: 10.1080/22423982.2021.1936974.

References

Chan S, Yu I . Quality of life of clients with schizophrenia. J Adv Nurs. 2003; 45(1):72-83. DOI: 10.1046/j.1365-2648.2003.02863.x. View

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

Pearlin L, Schooler C . The structure of coping. J Health Soc Behav. 1978; 19(1):2-21. View

Ching H, Burke V, Stuckey B . Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol (Oxf). 2007; 66(3):373-9. DOI: 10.1111/j.1365-2265.2007.02742.x. View

Carver C . You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997; 4(1):92-100. DOI: 10.1207/s15327558ijbm0401_6. View

Glueck C, Morrison J, Friedman L, Goldenberg N, Stroop D, Wang P . Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism. 2006; 55(4):508-14. DOI: 10.1016/j.metabol.2005.11.003. View

Upadhya K, Trent M . Effects of polycystic ovary syndrome on health-related quality of life. Expert Rev Pharmacoecon Outcomes Res. 2010; 7(6):597-603. DOI: 10.1586/14737167.7.6.597. View

Jones G, Palep-Singh M, Ledger W, Balen A, Jenkinson C, Campbell M . Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes. 2010; 8:149. PMC: 3024276. DOI: 10.1186/1477-7525-8-149. View

Elsenbruch S, Hahn S, Kowalsky D, Offner A, Schedlowski M, Mann K . Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(12):5801-7. DOI: 10.1210/jc.2003-030562. View

10.

Carver C, Pozo C, Harris S, Noriega V, Scheier M, Robinson D . How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Soc Psychol. 1993; 65(2):375-90. DOI: 10.1037//0022-3514.65.2.375. View

11.

Benson S, Hahn S, Tan S, Janssen O, Schedlowski M, Elsenbruch S . Maladaptive coping with illness in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2010; 39(1):37-45. DOI: 10.1111/j.1552-6909.2009.01086.x. View

12.

Drosdzol A, Skrzypulec V, Mazur B, Pawlinska-Chmara R . Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome. Folia Histochem Cytobiol. 2008; 45 Suppl 1:S93-7. View

13.

Banaszewska B, Duleba A, Spaczynski R, Pawelczyk L . Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol. 2006; 194(5):1266-72. DOI: 10.1016/j.ajog.2005.11.009. View

14.

Benson S, Hahn S, Tan S, Mann K, Janssen O, Schedlowski M . Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod. 2009; 24(6):1446-51. DOI: 10.1093/humrep/dep031. View